Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2013, Article ID 597920, 14 pages
http://dx.doi.org/10.1155/2013/597920
Review Article

Interactions between Cytokines, Congenital Anomalies of Kidney and Urinary Tract and Chronic Kidney Disease

1Pediatric Nephrology Unit, Department of Pediatrics, Federal University of Minas Gerais (UFMG), 30130-100 Belo Horizonte, MG, Brazil
2National Institute of Science and Technology of Molecular Medicine (INCT-MM), Faculty of Medicine, UFMG, 30130-100 Belo Horizonte, MG, Brazil
3Interdisciplinary Laboratory of Medical Investigation, Avenida Alfredo Balena, 190, 2nd Foor, Room No. 281, Faculty of Medicine, UFMG, 30130-100 Belo Horizonte, MG, Brazil

Received 29 March 2013; Revised 18 July 2013; Accepted 25 July 2013

Academic Editor: Osamu Takase

Copyright © 2013 Ana Cristina Simões e Silva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. R. Estrada Jr., “Prenatal hydronephrosis: early evaluation,” Current Opinion in Urology, vol. 18, no. 4, pp. 401–403, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. R. S. Lee, M. Cendron, D. D. Kinnamon, and H. T. Nguyen, “Antenatal hydronephrosis as a predictor of postnatal outcome: a meta-analysis,” Pediatrics, vol. 118, no. 2, pp. 586–593, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Mallik and A. R. Watson, “Antenatally detected urinary tract abnormalities: more detection but less action,” Pediatric Nephrology, vol. 23, no. 6, pp. 897–904, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. T. E. Cohen-Overbeek, P. Wijngaard-Boom, N. T. C. Ursem, W. C. J. Hop, J. W. Wladimiroff, and K. P. Wolffenbuttel, “Mild renal pyelectasis in the second trimester: determination of cut-off levels for postnatal referral,” Ultrasound in Obstetrics and Gynecology, vol. 25, no. 4, pp. 378–383, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. M. C. F. Bouzada, E. A. Oliveira, A. K. Pereira et al., “Diagnostic accuracy of fetal renal pelvis anteroposterior diameter as a predictor of uropathy: a prospective study,” Ultrasound in Obstetrics and Gynecology, vol. 24, no. 7, pp. 745–749, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. D. E. Coplen, P. F. Austin, Y. Yan, V. M. Blanco, and J. M. Dicke, “The magnitude of fetal renal pelvic dilatation can identify obstructive postnatal hydronephrosis, and direct postnatal evaluation and management,” Journal of Urology, vol. 176, no. 2, pp. 724–727, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Gramellini, S. Fieni, E. Caforio et al., “Diagnostic accuracy of fetal renal pelvis anteroposterior diameter as a predictor of significant postnatal nephrouropathy: second versus third trimester of pregnancy,” The American Journal of Obstetrics and Gynecology, vol. 194, no. 1, pp. 167–173, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. H. T. Nguyen, C. D. A. Herndon, C. Cooper et al., “The society for fetal urology consensus statement on the evaluation and management of antenatal hydronephrosis,” Journal of Pediatric Urology, vol. 6, no. 3, pp. 212–231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. C. S. Dias, J. M. P. Silva, A. K. Pereira et al., “Diagnostic accuracy of renal pelvic dilatation for detecting surgically managed ureteropelvic junction obstruction,” Journal of Urology, vol. 190, no. 2, pp. 661–666, 2013. View at Publisher · View at Google Scholar
  10. C. S. Dias, M. C. F. Bouzada, A. K. Pereira et al., “Predictive factors for vesicoureteral reflux and prenatally diagnosed renal pelvic dilatation,” Journal of Urology, vol. 182, no. 5, pp. 2440–2445, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. V. Phan, J. Traubici, B. Hershenfield, D. Stephens, N. D. Rosenblum, and D. F. Geary, “Vesicoureteral reflux in infants with isolated antenatal hydronephrosis,” Pediatric Nephrology, vol. 18, no. 12, pp. 1224–1228, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. G. M. Coelho, M. C. F. Bouzada, G. S. Lemos, A. K. Pereira, B. P. Lima, and E. A. Oliveira, “Risk factors for urinary tract infection in children with prenatal renal pelvic dilatation,” Journal of Urology, vol. 179, no. 1, pp. 284–289, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Farhat, G. McLorie, D. Geary et al., “The natural history of neonatal vesicoureteral reflux associated with antenatal hydronephrosis,” Journal of Urology, vol. 164, no. 3, pp. 1057–1060, 2000. View at Google Scholar · View at Scopus
  14. K. Ismaili, M. Hall, C. Donner, D. Thomas, D. Vermeylen, and F. E. Avni, “Results of systematic screening for minor degrees of fetal renal pelvis dilatation in an unselected population,” The American Journal of Obstetrics and Gynecology, vol. 188, no. 1, pp. 242–246, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Moorthy, N. Joshi, J. V. Cook, and M. Warren, “Antenatal hydronephrosis: negative predictive value of normal postnatal ultrasound—a 5-year study,” Clinical Radiology, vol. 58, no. 12, pp. 964–970, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. J. M. Tibballs and R. de Bruyn, “Primary vesicoureteric reflux—how useful is postnatal ultrasound?” Archives of Disease in Childhood, vol. 75, no. 5, pp. 444–447, 1996. View at Google Scholar · View at Scopus
  17. S. Toiviainen-Salo, L. Garel, A. Grignon et al., “Fetal hydronephrosis: is there hope for consensus?” Pediatric Radiology, vol. 34, no. 7, pp. 519–529, 2004. View at Google Scholar · View at Scopus
  18. V. Y. Leung, W. C. Chu, and C. Metreweli, “Hydronephrosis index: a better physiological reference in antenatal ultrasound for assessment of fetal hydronephrosis,” Journal of Pediatrics, vol. 154, no. 1, pp. 116–120, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Ismaili, M. Hall, A. Piepsz, M. Alexander, C. Schulman, and F. E. Avni, “Insights into the pathogenesis and natural history of fetuses with renal pelvis dilatation,” European Urology, vol. 48, no. 2, pp. 207–214, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. K. C. Hubert and J. S. Palmer, “Current diagnosis and management of fetal genitourinary abnormalities,” Urologic Clinics of North America, vol. 34, no. 1, pp. 89–101, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Piepsz, “Antenatally detected hydronephrosis,” Seminars in Nuclear Medicine, vol. 37, no. 4, pp. 249–260, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. R. S. Lee, “Biomarkers for pediatric urological disease,” Current Opinion in Urology, vol. 19, no. 4, pp. 397–401, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. J. LaBaer, “So, you want to look for biomarkers (introduction to the special biomarkers issue),” Journal of Proteome Research, vol. 4, no. 4, pp. 1053–1059, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Muller, S. Dreux, F. Audibert et al., “Fetal serum β2-microglobulin and cystatin C in the prediction of post-natal renal function in bilateral hypoplasia and hyperechogenic enlarged kidneys,” Prenatal Diagnosis, vol. 24, no. 5, pp. 327–332, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. H. G. O. Mesrobian, M. E. Mitchell, W. A. See et al., “Candidate urinary biomarker discovery in ureteropelvic junction obstruction: a proteomic approach,” Journal of Urology, vol. 184, no. 2, pp. 709–714, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Almodhen, O. Loutochin, J. P. Capolicchio, R. Jednak, and M. El-Sherbiny, “The role of bladder urine transforming growth factor-β1 concentrations in diagnosis and management of unilateral prenatal hydronephrosis,” Journal of Urology, vol. 182, no. 1, pp. 292–298, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. J. G. Wen, J. Frøkiær, T. M. Jørgensen, and J. C. Djurhuus, “Obstructive nephropathy: an update of the experimental research,” Urological Research, vol. 27, no. 1, pp. 29–39, 1999. View at Publisher · View at Google Scholar
  28. S. Klahr and J. Morrissey, “Obstructive nephropathy and renal fibrosis,” The American Journal of Physiology—Renal Physiology, vol. 283, no. 5, pp. F861–F875, 2002. View at Google Scholar · View at Scopus
  29. C. Alberti, “Congenital ureteropelvic junction obstruction: physiopathology, decoupling of tout court pelvic dilatation-obstruction semantic connection, biomarkers to predict renal damage evolution,” European Review for Medical and Pharmacological Sciences, vol. 16, no. 2, pp. 213–219, 2012. View at Google Scholar · View at Scopus
  30. R. L. Chevalier, B. A. Thornhill, M. S. Forbes, and S. C. Kiley, “Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy,” Pediatric Nephrology, vol. 25, no. 4, pp. 687–697, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. D. G. Matsell and A. F. Tarantal, “Experimental models of fetal obstructive nephropathy,” Pediatric Nephrology, vol. 17, no. 7, pp. 470–476, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Klahr, “Obstructive nephropathy,” Kidney International, vol. 54, no. 1, pp. 286–300, 1998. View at Google Scholar · View at Scopus
  33. L. C. Borish and J. W. Steinke, “Cytokines and chemokines,” Journal of Allergy and Clinical Immunology, vol. 111, no. 2, pp. S460–S475, 2003. View at Google Scholar · View at Scopus
  34. S. Segerer and C. E. Alpers, “Chemokines and chemokine receptors in renal pathology,” Current Opinion in Nephrology and Hypertension, vol. 12, no. 3, pp. 243–249, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Segerer, P. J. Nelson, and D. Schlöndorff, “Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies,” Journal of the American Society of Nephrology, vol. 11, no. 1, pp. 152–176, 2000. View at Google Scholar · View at Scopus
  36. C. Viedt, R. Dechend, J. Fei, G. M. Hänsch, J. Kreuzer, and S. R. Orth, “MCP-1 induces inflammatory activation of human tubular epithelial cells: involvement of the transcription factors, nuclear factor-κB and activating protein-1,” Journal of the American Society of Nephrology, vol. 13, no. 6, pp. 1534–1547, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. H. J. Gröne, C. D. Cohen, E. Gröne et al., “Spatial and temporally restricted expression of chemokines and chemokine receptors in the developing human kidney,” Journal of the American Society of Nephrology, vol. 13, no. 4, pp. 957–967, 2002. View at Google Scholar
  38. J. N. Sheu, M. C. Chen, S. L. Cheng, I. C. Lee, S. M. Chen, and G. J. Tsay, “Urine interleukin-1β in children with acute pyelonephritis and renal scarring,” Nephrology, vol. 12, no. 5, pp. 487–493, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. J. N. Sheu, M. C. Chen, K. H. Lue et al., “Serum and urine levels of interleukin-6 and interleukin-8 in children with acute pyelonephritis,” Cytokine, vol. 36, no. 5-6, pp. 276–282, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. M. F. O. Souto, A. L. Teixeira, R. C. Russo et al., “Immune mediators in idiopathic nephrotic syndrome: evidence for a relation between interleukin 8 and proteinuria,” Pediatric Research, vol. 64, no. 6, pp. 637–642, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Decramer, J. I. Bascands, and J. P. Schanstra, “Non-invasive markers of ureteropelvic junction obstruction,” World Journal of Urology, vol. 25, no. 5, pp. 457–465, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Artifoni, S. Negrisolo, G. Montini et al., “Interleukin-8 and CXCR1 receptor functional polymorphisms and susceptibility to acute pyelonephritis,” Journal of Urology, vol. 177, no. 3, pp. 1102–1106, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Monga, L. L. Gabal-Shehab, and P. Stein, “Urinary transforming growth factor-β1 levels correlate with bladder outlet obstruction,” International Journal of Urology, vol. 8, no. 9, pp. 487–489, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Klahr and J. J. Morrissey, “Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring,” Kidney International, Supplement, vol. 51, no. 63, pp. S111–S114, 1997. View at Google Scholar · View at Scopus
  45. A. Miyajima, J. Chen, C. Lawrence et al., “Antibody to transforming growth factor-β ameliorates tubular apoptosis in unilateral ureteral obstruction,” Kidney International, vol. 58, no. 6, pp. 2301–2313, 2000. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Trachtman, A. C. Weiser, E. Valderrama, M. Morgado, and L. S. Palmer, “Prevention of renal fibrosis by spironolactone in mice with complete unilateral ureteral obstruction,” Journal of Urology, vol. 172, no. 4, pp. 1590–1594, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. F. Seseke, P. Thelen, M. Heuser, G. Zöller, and R. H. Ringert, “Impaired nephrogenesis in rats with congenital obstructive uropathy,” Journal of Urology, vol. 165, no. 6, pp. 2289–2292, 2001. View at Google Scholar · View at Scopus
  48. R. L. Chevalier, B. A. Thornhill, A. Y. Chang, F. Cachat, and A. Lackey, “Recovery from release of ureteral obstruction in the rat: relationship to nephrogenesis,” Kidney International, vol. 61, no. 6, pp. 2033–2043, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Stephan, S. Conrad, T. Eggert, R. Heuer, S. Fernandez, and H. Huland, “Urinary concentration and tissue messenger RNA expression of monocyte chemoattractant protein-1 as an indicator of the degree of hydronephrotic atrophy in partial ureteral obstruction,” Journal of Urology, vol. 167, no. 3, pp. 1497–1502, 2002. View at Google Scholar · View at Scopus
  50. F. Seseke, P. Thelen, B. Hemmerlein, D. Kliese, G. Zöller, and R. H. Ringert, “Histologic and molecular evidence of obstructive uropathy in rats with hereditary congenital hydronephrosis,” Urological Research, vol. 28, no. 2, pp. 104–109, 2000. View at Google Scholar · View at Scopus
  51. R. L. Chevalier, B. A. Thornhill, J. T. Wolstenholme, and A. Kim, “Unilateral ureteral obstruction in early development alters renal growth: dependence on the duration of obstruction,” Journal of Urology, vol. 161, no. 1, pp. 309–313, 1999. View at Publisher · View at Google Scholar · View at Scopus
  52. Y. Zhou, G. Takahashi, T. Shinagawa et al., “Increased transforming growth factor-β1 and tubulointerstitial fibrosis in rats with congenital hydronephrosis,” International Journal of Urology, vol. 9, no. 9, pp. 491–500, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. L. D. Truong, G. Petrusevska, G. Yang et al., “Cell apoptosis and proliferation in experimental chronic obstructive uropathy,” Kidney International, vol. 50, no. 1, pp. 200–207, 1996. View at Google Scholar · View at Scopus
  54. L. D. Truong, Y. J. Choi, C. C. Chun et al., “Renal cell apoptosis in chronic obstructive uropathy: the roles of caspases,” Kidney International, vol. 60, no. 3, pp. 924–934, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. R. L. Chevalier, S. Goyal, J. T. Wolstenholme, and B. A. Thornhill, “Obstructive nephropathy in the neonatal rat is attenuated by epidermal growth factor,” Kidney International, vol. 54, no. 1, pp. 38–47, 1998. View at Publisher · View at Google Scholar · View at Scopus
  56. G. M. Seremetis and M. Maizels, “TGF-β mRNA expression in the renal pelvis after experimental and clinical ureteropelvic junction obstruction,” Journal of Urology, vol. 156, no. 1, pp. 261–266, 1996. View at Publisher · View at Google Scholar · View at Scopus
  57. Y. Isaka, M. Tsujie, Y. Ando et al., “Transforming growth factor-β1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction,” Kidney International, vol. 58, no. 5, pp. 1885–1892, 2000. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Mizuno, K. Matsumoto, and T. Nakamura, “Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy,” Kidney International, vol. 59, no. 4, pp. 1304–1314, 2001. View at Publisher · View at Google Scholar · View at Scopus
  59. R. Derynck, Y. Zhang, and X. H. Feng, “Smads: transcriptional activators of TGF-β responses,” Cell, vol. 95, no. 6, pp. 737–740, 1998. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Sato, Y. Muragaki, S. Saika, A. B. Roberts, and A. Ooshima, “Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction,” Journal of Clinical Investigation, vol. 112, no. 10, pp. 1486–1494, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. R. Misseri, D. R. Meldrum, P. Dagher, K. Hile, R. C. Rink, and K. K. Meldrum, “Unilateral ureteral obstruction induces renal tubular cell production of tumor necrosis factor-α independent of inflammatory cell infiltration,” Journal of Urology, vol. 172, no. 4, pp. 1595–1599, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. V. Vielhauer, H. J. Anders, M. Mack et al., “Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes,” Journal of the American Society of Nephrology, vol. 12, no. 6, pp. 1173–1187, 2001. View at Google Scholar · View at Scopus
  63. J. M. Crisman, L. L. Richards, D. P. Valach, D. F. Franzoni, and J. R. Diamond, “Chemokine expression in the obstructed kidney,” Experimental Nephrology, vol. 9, no. 4, pp. 241–248, 2001. View at Google Scholar · View at Scopus
  64. A. J. Lauder, H. E. Jolin, P. Smith et al., “Lymphomagenesis, hydronephrosis, and autoantibodies result from dysregulation of IL-9 and are differentially dependent on Th2 cytokines,” Journal of Immunology, vol. 173, no. 1, pp. 113–122, 2004. View at Google Scholar · View at Scopus
  65. M. G. Madsen, “Urinary biomarkers in hydronephrosis,” Danish Medical Journal, vol. 60, no. 2, Article ID B4582, 2013. View at Google Scholar
  66. Y. H. Chuang, W. L. Chuang, S. P. Huang, C. K. Liu, and C. H. Huang, “Atorvastatin ameliorates tissue damage of obstructed ureter in rats,” Life Sciences, vol. 89, no. 21-22, pp. 795–805, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. D. Hochberg, C. W. Johnson, J. Chen et al., “Interstitial fibrosis of unilateral ureteral obstruction is exacerbated in kidneys of mice lacking the gene for inducible nitric oxide synthase,” Laboratory Investigation, vol. 80, no. 11, pp. 1721–1728, 2000. View at Google Scholar · View at Scopus
  68. D. I. Bulas and J. S. Fonda, “Prenatal evaluation of fetal anomalies,” Pediatric Clinics of North America, vol. 44, no. 3, pp. 537–553, 1997. View at Publisher · View at Google Scholar · View at Scopus
  69. P. L. Zhang, C. A. Peters, and S. Rosen, “Ureteropelvic junction obstruction: morphological and clinical studies,” Pediatric Nephrology, vol. 14, no. 8-9, pp. 820–826, 2000. View at Publisher · View at Google Scholar · View at Scopus
  70. G. Grandaliano, L. Gesualdo, F. Bartoli et al., “MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy,” Kidney International, vol. 58, no. 1, pp. 182–192, 2000. View at Publisher · View at Google Scholar · View at Scopus
  71. F. Bartoli, L. Gesualdo, G. Paradies et al., “Renal expression of monocyte chemotactic protein-1 and epidermal growth factor in children with obstructive hydronephrosis,” Journal of Pediatric Surgery, vol. 35, no. 4, pp. 569–572, 2000. View at Google Scholar · View at Scopus
  72. F. Bartoli, R. Penza, G. Aceto et al., “Urinary epidermal growth factor, monocyte chemotactic protein-1, and β2-microglobulin in children with ureteropelvic junction obstruction,” Journal of Pediatric Surgery, vol. 46, no. 3, pp. 530–536, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. M. G. Madsen, R. Nørregaard, J. Palmfeldt, L. H. Olsen, J. Frøkiær, and T. M. Jørgensen, “Epidermal growth factor and monocyte chemotactic peptide-1: potential biomarkers of urinary tract obstruction in children with hydronephrosis,” Journal of Pediatric Urology, 2012. View at Publisher · View at Google Scholar
  74. K. Taranta-Janusz, A. Wasilewska, W. Dębek, and M. Waszkiewicz-Stojda, “Urinary cytokine profiles in unilateral congenital hydronephrosis,” Pediatric Nephrology, vol. 27, no. 11, pp. 2107–2113, 2012. View at Publisher · View at Google Scholar
  75. L. S. Palmer, M. Maizels, W. E. Kaplan, C. F. Firlit, and E. Y. Cheng, “Urine levels of transforming growth factor-β 1 in children with ureteropelvic junction obstruction,” Urology, vol. 50, no. 5, pp. 769–773, 1997. View at Publisher · View at Google Scholar · View at Scopus
  76. P. D. Furness III, M. Maizels, S. W. Han, R. A. Cohn, and E. Y. Cheng, “Elevated bladder urine concentration of transforming growth factor-β1 correlates with upper urinary tract obstruction in children,” Journal of Urology, vol. 162, no. 3, part 2, pp. 1033–1036, 1999. View at Publisher · View at Google Scholar · View at Scopus
  77. C. Sager, J. C. Lopez, V. Duran, C. Burek, and E. Perazzo, “Transforming growth factor-β1 in congenital ureteropelvic junction obstruction: diagnosis and follow-up,” International Brazilian Journal of Urology, vol. 35, no. 3, pp. 315–324, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. M. T. El-Sherbiny, O. M. Mousa, A. A. Shokeir, and M. A. Ghoneim, “Role of urinary transforming growth factor-β1 concentration in the diagnosis of upper urinary tract obstruction in children,” Journal of Urology, vol. 168, no. 4, pp. 1798–1800, 2002. View at Google Scholar · View at Scopus
  79. M. A. Taha, A. A. Shokeir, H. G. Osman, A. E. F. Abd El-Aziz, and S. E. Farahat, “Pelvi-ureteric junction obstruction in children: the role of urinary transforming growth factor-β1 and epidermal growth factor,” BJU International, vol. 99, no. 4, pp. 899–903, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. J. Zieg, K. Blahova, T. Seeman et al., “Urinary transforming growth factor-β1 in children with obstructive uropathy,” Nephrology, vol. 16, no. 6, pp. 595–598, 2011. View at Publisher · View at Google Scholar · View at Scopus
  81. J. S. Elder, C. A. Peters, B. S. Arant Jr. et al., “Pediatric vesicoureteral reflux guidelines panel summary report on the management of primary vesicoureteral reflux in children,” Journal of Urology, vol. 157, no. 5, pp. 1846–1851, 1997. View at Publisher · View at Google Scholar · View at Scopus
  82. J. M. P. Silva, J. S. S. Diniz, A. C. Simões e Silva, M. V. Azevedo, M. R. Pimenta, and E. A. Oliveira, “Predictive factors of chronic kidney disease in severe vesicoureteral reflux,” Pediatric Nephrology, vol. 21, no. 9, pp. 1285–1292, 2006. View at Publisher · View at Google Scholar · View at Scopus
  83. B. Chertin, A. Farkas, and P. Puri, “Epidermal growth factor and monocyte chemotactic peptide-1 expression in reflux nephropathy,” European Urology, vol. 44, no. 1, pp. 144–149, 2003. View at Publisher · View at Google Scholar · View at Scopus
  84. M. Haraoka, K. Senoh, N. Ogata, M. Furukawa, T. Matsumoto, and J. Kumazawa, “Elevated interleukin-8 levels in the urine of children with renal scarring and/or vesicoureteral reflux,” Journal of Urology, vol. 155, no. 2, pp. 678–680, 1996. View at Publisher · View at Google Scholar · View at Scopus
  85. G. K. Ninan, R. S. Jutley, and O. Eremin, “Urinary cytokines as markers of reflux nephropathy,” Journal of Urology, vol. 162, no. 5, pp. 1739–1742, 1999. View at Publisher · View at Google Scholar · View at Scopus
  86. J. Wang, R. Konda, H. Sato, K. Sakai, S. Ito, and S. Orikasa, “Clinical significance of urinary interleukin-6 in children with reflux nephropathy,” Journal of Urology, vol. 165, no. 1, pp. 210–214, 2001. View at Google Scholar · View at Scopus
  87. E. Galanakis, M. Bitsori, H. Dimitriou, C. Giannakopoulou, N. S. Karkavitsas, and M. Kalmanti, “Urine interleukin-8 as a marker of vesicoureteral reflux in infants,” Pediatrics, vol. 117, no. 5, pp. e863–e867, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. A. Sabasiñska, W. Zoch-Zwierz, A. Wasilewska, and T. Porowski, “Laminin and transforming growth factor β-1 in children with vesicoureteric reflux,” Pediatric Nephrology, vol. 23, no. 5, pp. 769–774, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. I. Gokce, H. Alpay, N. Biyikli, G. Unluguzel, F. Dede, and A. Topuzoglu, “Urinary levels of interleukin-6 and interleukin-8 in patients with vesicoureteral reflux and renal parenchymal scar,” Pediatric Nephrology, vol. 25, no. 5, pp. 905–912, 2010. View at Publisher · View at Google Scholar · View at Scopus
  90. A. R. Merrikhi, M. Keivanfar, A. Gheissari, and F. Mousavinasab, “Urine interlukein-8 as a diagnostic test for vesicoureteral reflux in children,” Journal of the Pakistan Medical Association, vol. 62, no. 3, supplement 2, pp. S52–S54, 2012. View at Google Scholar
  91. D. Tramma, M. Hatzistylianou, G. Gerasimou, and V. Lafazanis, “Interleukin-6 and interleukin-8 levels in the urine of children with renal scarring,” Pediatric Nephrology, vol. 27, no. 9, pp. 1525–1530, 2012. View at Publisher · View at Google Scholar · View at Scopus
  92. H. E. Yim, I. S. Bae, K. H. Yoo, Y. S. Hong, and J. W. Lee, “Genetic control of VEGF and TGF-β1 gene polymorphisms in childhood urinary tract infection and vesicoureteral reflux,” Pediatric Research, vol. 62, no. 2, pp. 183–187, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. S. Kuroda, V. Solari, and P. Puri, “Association of transforming growth factor-β1 gene polymorphism with familial vesicoureteral reflux,” Journal of Urology, vol. 178, no. 4, pp. 1650–1653, 2007. View at Publisher · View at Google Scholar · View at Scopus
  94. G. J. Lee-Chen, P. K. Liu, Y. C. Lai, H. S. Juang, S. Y. Huang, and C. Y. Lin, “Significance of the tissue kallikrein promoter and transforming growth factor-β1 polymorphisms with renal progression in children with vesicoureteral reflux,” Kidney International, vol. 65, no. 4, pp. 1467–1472, 2004. View at Publisher · View at Google Scholar · View at Scopus
  95. V. Solari, S. Ennis, S. Cascio, and P. Puri, “Tumor necrosis factor-α gene polymorphism in reflux nephropathy,” Journal of Urology, vol. 172, no. 4, pp. 1604–1606, 2004. View at Publisher · View at Google Scholar · View at Scopus
  96. A. Hussein, E. Askar, M. Elsaeid, and F. Schaefer, “Functional polymorphisms in transforming growth factor-β-1 (TGFβ-1) and vascular endothelial growth factor (VEGF) genes modify risk of renal parenchymal scarring following childhood urinary tract infection,” Nephrology Dialysis Transplantation, vol. 25, no. 3, pp. 779–785, 2010. View at Publisher · View at Google Scholar · View at Scopus
  97. C. Schwentner, J. Oswald, A. Lunacek et al., “Extracellular microenvironment and cytokine profile of the ureterovesical junction in children with vesicoureteral reflux,” Journal of Urology, vol. 180, no. 2, pp. 694–700, 2008. View at Publisher · View at Google Scholar · View at Scopus
  98. H. R. Vianna, C. M. Soares, K. D. Silveira et al., “Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases,” Pediatric Nephrology, vol. 28, no. 3, pp. 463–469, 2013. View at Publisher · View at Google Scholar
  99. R. S. Jutley, G. G. Youngson, O. Eremin, and G. K. Ninan, “Serum cytokine profile in reflux nephropathy,” Pediatric Surgery International, vol. 16, no. 1-2, pp. 64–68, 2000. View at Google Scholar · View at Scopus
  100. M. A. Vasconcelos, M. C. F. Bouzada, K. D. Silveira et al., “Urinary levels of TGF β-1 and of cytokines in patients with prenatally detected nephrouropathies,” Pediatric Nephrology, vol. 26, no. 5, pp. 739–747, 2011. View at Publisher · View at Google Scholar · View at Scopus
  101. J. Harambat, K. J. van Stralen, J. J. Kim, and E. J. Tizard, “Epidemiology of chronic kidney disease in children,” Pediatric Nephrology, vol. 27, no. 3, pp. 363–373, 2012. View at Publisher · View at Google Scholar · View at Scopus
  102. F. Daïkha-Dahmane, M. Dommergues, F. Muller et al., “Development of human fetal kidney in obstructive uropathy: correlations with ultrasonography and urine biochemistry,” Kidney International, vol. 52, no. 1, pp. 21–32, 1997. View at Google Scholar · View at Scopus